The first half’s sales performance of listed pharmaceutical company was ‘Good’
Despite various policy restrictions and the MERS crisis, it is analyzed that listed pharmaceutical companies made decent sales and profits in the first half of the year.
According to the YakupDotCom’s analysis result of the first half’s sales performance of 59 KOSPI and KOSDAQ listed pharmaceuti...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
